BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37685852)

  • 1. Improving Cancer Targeting: A Study on the Effect of Dual-Ligand Density on Targeting of Cells Having Differential Expression of Target Biomarkers.
    Sultana N; David AE
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
    Patel K; Sundara Raj B; Chen Y; Lou X
    Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
    Sharma M; Malik R; Verma A; Dwivedi P; Banoth GS; Pandey N; Sarkar J; Mishra PR; Dwivedi AK
    J Biomed Nanotechnol; 2013 Jan; 9(1):96-106. PubMed ID: 23627072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.
    Jang C; Lee JH; Sahu A; Tae G
    Nanoscale; 2015 Nov; 7(44):18584-94. PubMed ID: 26489965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
    J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
    Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-ligand functionalized carbon nanodots as green fluorescent nanosensors for cellular dual receptor-mediated targeted imaging.
    Du F; Zhao X; Lu W; Guo Z; Shuang S; Dong C
    Analyst; 2019 Nov; 144(22):6729-6735. PubMed ID: 31612877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-decorated alginate nanoparticles loaded hydrogel for the oral delivery of diferourylmethane in colorectal cancer.
    Abbasi M; Sohail M; Minhas MU; Mahmood A; Shah SA; Munir A; Kashif MU
    Int J Biol Macromol; 2023 Apr; 233():123585. PubMed ID: 36758757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System.
    Zhao Y; Ding W; Zhang P; Deng L; Long Y; Lu J; Shiri F; Heidari Majd M
    Anticancer Agents Med Chem; 2024 Apr; ():. PubMed ID: 38685808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
    Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
    J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
    Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
    Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
    Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
    Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
    Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors.
    Yan Y; Dong Y; Yue S; Qiu X; Sun H; Zhong Z
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46548-46557. PubMed ID: 31763810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.